The EndoBarrier™ Gastrointestinal Liner is a breakthrough treatment designed to help patients regain metabolic control of Type 2 Diabetes and to aid in weight loss.
This is a new class of treatment that fits between pharmaceutical regimens and surgery. It is performed easily and quickly without any incisions and just a few hours in hospital. Based on the growing body of clinical evidence, EndoBarrier™ has the potential to dramatically change the treatment approach for people who are obese or have Type 2 Diabetes.
Clinical experience has found that EndoBarrier™ can provide immediate relief from Type 2 Diabetes in patients with significantly elevated HbA1c. In addition, most patients experience clinically significant weight loss.